Innovation Pharmaceuticals Inc. – OTC:IPIX
Innovation Pharmaceuticals stock price today
Innovation Pharmaceuticals stock price monthly change
Innovation Pharmaceuticals stock price quarterly change
Innovation Pharmaceuticals stock price yearly change
Innovation Pharmaceuticals key metrics
Market Cap | 9.82M |
Enterprise value | 6.42M |
P/E | -1.77 |
EV/Sales | 357.01 |
EV/EBITDA | -1.44 |
Price/Sales | 482.84 |
Price/Book | 2.82 |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | -4.03M |
Income | -4.75M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | -27227.78% |
Oper. margin | -25800% |
Gross margin | 0% |
EBIT margin | -25800% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeInnovation Pharmaceuticals stock price history
Innovation Pharmaceuticals stock forecast
Innovation Pharmaceuticals financial statements
| Mar 2022 | 0 | -1.51M | |
|---|---|---|---|
| Jun 2022 | 18K | -1.82M | -10144.44% |
| Mar 2023 | 0 | -729K | |
| Jun 2023 | -6K | -681K | 11350% |
| Payout ratio | 0% |
|---|
| 2019 | |
|---|---|
| 2020 | |
| 2021 | |
| 2022 | |
| 2023 | 0.85% |
| Sep 2022 | 9338000 | 5.91M | 63.36% |
|---|---|---|---|
| Dec 2022 | 8691000 | 5.61M | 64.55% |
| Mar 2023 | 7993000 | 5.27M | 66.02% |
| Jun 2023 | 7517000 | 5.47M | 72.87% |
| Mar 2022 | -1.12M | -6K | 0 |
|---|---|---|---|
| Jun 2022 | -958K | -4.03M | -3.97M |
| Mar 2023 | -469K | -17K | 3K |
| Jun 2023 | -369K | -12K | -41K |
Innovation Pharmaceuticals alternative data
| Aug 2023 | 4 |
|---|---|
| Sep 2023 | 4 |
| Oct 2023 | 4 |
| Nov 2023 | 4 |
| Dec 2023 | 4 |
| Jan 2024 | 4 |
| Feb 2024 | 4 |
| Mar 2024 | 4 |
| Apr 2024 | 4 |
| May 2024 | 4 |
| Jun 2024 | 4 |
| Jul 2024 | 4 |
Innovation Pharmaceuticals other data
| Period | Buy | Sel |
|---|---|---|
| Jul 2010 | 1000000 | 0 |
| Insider | Compensation |
|---|---|
Mr. Leo Ehrlich CPA (1958) Chairman, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer & Sec. | $515,850 |
Ms. Jane Harness M.S., MP, MS (1968) Senior Vice President of Clinical Sciences & Portfolio Management | $365,750 |
Monday, 20 May 2024 | ||
| INVNT™ Announced as Sponsor and Co-Producer of Discovery Stage at SXSW Sydney® 2024 | https://www.businesswire.com |
-
What's the price of Innovation Pharmaceuticals stock today?
One share of Innovation Pharmaceuticals stock can currently be purchased for approximately $0.02.
-
When is Innovation Pharmaceuticals's next earnings date?
Unfortunately, Innovation Pharmaceuticals's (IPIX) next earnings date is currently unknown.
-
Does Innovation Pharmaceuticals pay dividends?
No, Innovation Pharmaceuticals does not pay dividends.
-
How much money does Innovation Pharmaceuticals make?
Innovation Pharmaceuticals has a market capitalization of 9.82M.
-
What is Innovation Pharmaceuticals's stock symbol?
Innovation Pharmaceuticals Inc. is traded on the OTC under the ticker symbol "IPIX".
-
What is Innovation Pharmaceuticals's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Innovation Pharmaceuticals?
Shares of Innovation Pharmaceuticals can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Innovation Pharmaceuticals's key executives?
Innovation Pharmaceuticals's management team includes the following people:
- Mr. Leo Ehrlich CPA Chairman, Chief Executive Officer, Chief Financial Officer, Principal Accounting Officer & Sec.(age: 67, pay: $515,850)
- Ms. Jane Harness M.S., MP, MS Senior Vice President of Clinical Sciences & Portfolio Management(age: 57, pay: $365,750)
-
How many employees does Innovation Pharmaceuticals have?
As Jul 2024, Innovation Pharmaceuticals employs 4 workers.
-
When Innovation Pharmaceuticals went public?
Innovation Pharmaceuticals Inc. is publicly traded company for more then 18 years since IPO on 4 May 2007.
-
What is Innovation Pharmaceuticals's official website?
The official website for Innovation Pharmaceuticals is ipharminc.com.
-
Where are Innovation Pharmaceuticals's headquarters?
Innovation Pharmaceuticals is headquartered at 301 Edgewater Place, Wakefield, MA.
-
How can i contact Innovation Pharmaceuticals?
Innovation Pharmaceuticals's mailing address is 301 Edgewater Place, Wakefield, MA and company can be reached via phone at 978 921 4125.
Innovation Pharmaceuticals company profile:
Innovation Pharmaceuticals Inc.
ipharminc.comOTC
4
Biotechnology
Healthcare
Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. The company's lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. It has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.
Wakefield, MA 01880
CIK: 0001355250
ISIN: US45782D1000
CUSIP: 45782D100
